Results for tag: "Late Phase Study"

The Late Phase Study market is a segment of the Clinical Trials industry that focuses on the evaluation of a drug or medical device after it has been approved for use in humans. This phase of clinical trials is typically conducted after the drug or device has been approved by the regulatory authorities and is available for use in the general population. The purpose of the late phase study is to further evaluate the safety and efficacy of the drug or device, as well as to assess its long-term effects. This phase of clinical trials is often conducted in a real-world setting, such as in a hospital or clinic, and may involve a large number of participants. Some companies in the Late Phase Study market include Parexel, ICON, Syneos Health, PPD, and Quintiles. Show Less Read more